share_log

SciBase Will Present at the Redeye Medtech Event on April 24th

SciBase Will Present at the Redeye Medtech Event on April 24th

SciBase 將於 4 月 24 日出席 Redeye Medtech 活動
PR Newswire ·  04/23 21:05

STOCKHOLM, April 23, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will participate at the Redeye Medtech event.

斯德哥爾摩,2024 年 4 月 23 日 /PRNewswire/ — SciBase Holding AB(“SciBase”) (停止:SCIB),基於增強智能的皮膚病解決方案的領先開發商 將參加 Redeye Medtech 活動。

On April 24 at CET 9.50 CEO Pia Renaudin will present the latest developments in SciBase at Redeye. The presentation is live broadcasted and can be followed at where the replay and the presentations will be available afterwards.

首席執行官皮亞·雷諾丁將於4月24日在歐洲中歐標準時間9點50分在Redeye上介紹SciBase的最新進展。該演示是現場直播的,可以在以下網址觀看 之後將提供重播和演示文稿。

For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]

欲了解更多信息,請聯繫:
Pia Renaudin,VD,電話 +46732069802,電子郵件:[email protected]

Certified Advisor (CA):

Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]

認證顧問 (CA):

Vator 證券
電話:+46 8 580 065 99
電子郵件:[電子郵件保護]

About SciBase:

關於 SciBase:

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.

SciBase 是一家全球醫療技術公司,專門從事皮膚病學的早期發現和預防。SciBase 開發並商業化了 Nevisense,這是一個獨特的即時護理平台,它結合了人工智能(人工智能)和先進的 EIS 技術,可提高診斷準確性,確保積極的皮膚健康管理。

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

我們的承諾是最大限度地減少患者的痛苦,使臨床醫生能夠通過及時的檢測和干預來改善和挽救生命,並降低醫療成本。

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

SciBase建立在瑞典斯德哥爾摩卡羅林斯卡研究所20多年的研究基礎上,是皮膚病學進步領域的領導者。

The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:

該公司自2015年6月2日起在納斯達克第一北方成長市場交易所上市。要了解更多,請訪問。所有新聞稿和財務報告都可以在這裏找到:

This information was brought to you by Cision

這些信息是由 Cision 帶給你的

The following files are available for download:

以下文件可供下載:

Redeye presentation

Redeye 演示文稿

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論